In addition, a recent study reported that SUMOylation of MORC2 at K767 attenuated the sensitivity of BC cells to DNA-damaging chemotherapeutic drugs, which may enhance the efficacy of chemotherapy in the treatment of MORC2-induced tumors by inhibiting its SUMOylation modification.114. Here, MORC2 is linked to breast cancer.